Potential oral VEGFR2 inhibitors: Treatment of wet age-related macular degeneration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential oral VEGFR2 inhibitors: Treatment of wet age-related macular degeneration

Published:2024-03 Issue: Volume:144 Page:107110
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Xiu Xiaomeng,Li Mengzhen,Hu Dexiang,Jia Hongwei,Wang Hanxun,Liu Yaoyang,Zhao Xueqi,Li Zhenli,Liu Yang,Yang Huali,Cheng Maosheng

Funder

Scientific Research Fund of Liaoning Provincial Education Department

Department of Education of Liaoning Province

Publisher

Elsevier BV

Reference31 articles.

1. Ranibizumab and bevacizumab for neovascular age-related macular degeneration;Martin;N. Engl. J. Med.,2011

2. Risk factors and biomarkers of age-related macular degeneration;Lambert;Prog. Retin. Eye Res.,2016

3. Mechanisms of age-related macular degeneration;Ambati;Neuron,2012

4. Age-related macular degeneration: current treatments;Hubschman;Clin. Ophthalmol.,2009

5. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders;Aiello;N. Engl. J. Med.,1994

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP